Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» NL-201
NL-201
FDA sideswipes Neoleukin with clinical hold on lead immunotherapy candidate, sends shares plummeting
FDA sideswipes Neoleukin with clinical hold on lead immunotherapy candidate, sends shares plummeting
Endpoints
Neoleukin
NL-201
FDA
natural killer cell therapy
oncology
clinical trials
Flag link:
